why choose us

First received: May 10, 2023

Clinical Trial: SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

Study Status: Completed

Recruit Status: RECRUITING

Condition: Spinal Cord Injuries

Study Type: OBSERVATIONAL


Official Title: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in People With Chronic Traumatic Spinal Cord Injury

Brief Summary: The purpose of this observational research study is to better understand immune responses to vaccines against viruses (influenza or SARS-CoV2).The goal is to determine any differences in immune responses to vaccines in uninjured people and in people living with spinal cord injuries, who are typically at increased risk of infections.

Read more